Product Details
REVONTO(DANTROLENE SOD)IV 20MG
Manufacturer: US WorldMeds
MFG#: 78670-0003-67
NDC: 78670-0003-67
PID: 313540
UN
$ *.**
In Stock6EA/BX
$ *.**
Limited QuantitiesProduct Properties:
| Description | N |
|---|---|
| DESI Drug Ind | -; - |
| HCPCS | 1 |
| Medical Coverage | - |
| Active Ingredients | 1675 dantrolene sodium 24868200 |
| AHFS Class | 12200800 DIRECT-ACTING SKELETAL MUSCLE RELAXANTS |
| DEA Class | NC |
| Dose Form | VIAL (EA) |
| Fine Line Class | 850085008510 All Rx Products |
| Gen Code and Des | 4669 dantrolene sodium INTRAVEN VIAL 20 MG |
| Inactive Ingredients | 2272 mannitol 69658 |
| OMP Family | - |
| Product Category | RX Pharmaceuticals |
| Strength | 20MG |
| Common Brand Name | - |
| Drug Interaction | - |
| Allocation Period | - |
| Case Quantity | 6 |
| Drug Form Pack Size | 6 |
| Form | VIAL |
| Hazard Code | - |
| Listed Chemical | - |
| NIOSH Code | - |
| Orange Book | AP Injectable aqueous solutions including dry powders, concentrated solutions or ready-to-use solutions are considered pharmaceutically and therapeutically equivalent if they produce the same concentration and are labeled similarly. |
| Retail Pack Quantity | 1 |
| Returnable Status | Not Returnable |
| Special Storage Cond | 00 None |
| Temp Zone | 10 Room Temperature |
| Unit | EA |
| Unit Size | 6 |
| How to Use | - |
| Missed Dose | 6 |
| Notes | EA |
| Overdose | AP |
| Phonetic Pronunciation | - |
| Precautions | - |
| Side Effects | - |
| Storage | 07/24/2007 |
| Uses | - |
Additional Information
| Product Name | Revonto (Dantrolene Sodium) IV 20 mg |
| Generic Drug Name | Dantrolene Sodium |
| Strength | 20 mg |
| Type | Intravenous |
| Application | Malignant Hyperthermia Treatment Agent |
| Container Type | Vial |
| Dosage Form | Injection |
| Volume | 65 mL |
| Features | Requires reconstitution with 60 mL sterile water, store at 20 to 25°C |
| Uses | Treats malignant hyperthermia; stabilizes muscle function and reduces body temperature |
Description
Revonto (Dantrolene Sodium) IV 20 mg is a critical medication used in the treatment of malignant hyperthermia, a severe reaction to certain anesthetics. Each 65 mL vial contains 20 mg of dantrolene sodium, a muscle relaxant that effectively counteracts the rapid increase in body temperature and muscle rigidity associated with this condition. The formulation also includes 3000 mg of mannitol, which acts as a stabilizing agent, and sodium hydroxide to adjust the pH to approximately 9.5 when reconstituted.
For optimal efficacy, Revonto should be stored unreconstituted at a temperature range of 20 to 25 degrees Celsius (68 to 77 degrees Fahrenheit). This storage condition helps maintain the stability and potency of the medication. Prior to administration, the product must be reconstituted with 60 mL of sterile water for injection USP, which is essential for preparing the solution for intravenous use.
Revonto's specific formulation and preparation guidelines ensure that the medication is both effective and safe for use in managing acute episodes of malignant hyperthermia. Its careful composition and handling instructions are critical for achieving the desired therapeutic outcomes in emergency medical settings.
Frequently Asked Questions (FAQs)
The cost of REVONTO(DANTROLENE SOD)IV 20MG is $$0.00
REVONTO(DANTROLENE SOD)IV 20MG is manufactured by US WorldMeds.
You can purchase REVONTO(DANTROLENE SOD)IV 20MG on our website at https://supplies.pipelinemedical.com/product/detail/revonto-20mg-vl-6-ds-313540